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Whole-Genome Analysis of Human Influenza A
Virus Reveals Multiple Persistent Lineages
and Reassortment among Recent H3N2 Viruses
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Understanding the evolution of influenza A viruses in humans is important for surveillance and vaccine strain
selection. We performed a phylogenetic analysis of 156 complete genomes of human H3N2 influenza A viruses
collected between 1999 and 2004 from New York State, United States, and observed multiple co-circulating clades with
different population frequencies. Strikingly, phylogenies inferred for individual gene segments revealed that multiple
reassortment events had occurred among these clades, such that one clade of H3N2 viruses present at least since 2000
had provided the hemagglutinin gene for all those H3N2 viruses sampled after the 2002–2003 influenza season.
This reassortment event was the likely progenitor of the antigenically variant influenza strains that caused the
A/Fujian/411/2002-like epidemic of the 2003–2004 influenza season. However, despite sharing the same
hemagglutinin, these phylogenetically distinct lineages of viruses continue to co-circulate in the same population.
These data, derived from the first large-scale analysis of H3N2 viruses, convincingly demonstrate that multiple lineages
can co-circulate, persist, and reassort in epidemiologically significant ways, and underscore the importance of genomic
analyses for future influenza surveillance.
Citation: Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, et al. (2005) Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment
among recent H3N2 viruses. PLoS Biol 3(9): e300.
Introduction
Inﬂuenza A viruses are negative-strand RNA viruses of the
Family Orthomyxoviridae that infect a wide variety of warm-
blooded animals, including domestic and wild birds and mam-
mals (e.g., humans, pigs, and horses). The natural reservoir for
inﬂuenza virus is thought to be wild waterfowl, and genetic
material from avian strains episodically emerges in strains
infectious to humans. These human viruses continually circu-
late in yearly epidemics (mainly during the winter months in
temperate climates), and antigenically novel strains emerge
sporadically as pandemic viruses [1,2]. In the United States,
inﬂuenza is estimated to kill 30,000 people in an average year
[3,4]. Every few years, inﬂuenza epidemics boost the annual
mortality level above this average, causing 10,000–15,000
additional deaths. Occasionally, and unpredictably, global
pandemics of inﬂuenza occur, infecting 20% to 40% of the
population in a single year and raising death rates dramatically
above normal levels. Pandemic inﬂuenza A viruses emerged
three times during the last century: in 1918 (H1N1 subtype), in
1957 (H2N2), and in 1968 (H3N2) [2,5]. The recent circulation
of highly pathogenic avian H5N1 viruses in Asia from 2003–
2005 has caused at least 52 human deaths [6,7] and has raised
concern about the development of a new pandemic [5]. How
and when novel inﬂuenza viruses emerge as pandemic strains
and their precise mechanisms of pathogenesis are still not
understood.
While the risk of pandemic inﬂuenza poses a signiﬁcant
public health concern, inter-pandemic or epidemic inﬂuenza
remains a major cause of morbidity and mortality. The
inﬂuenza A surface glycoprotein hemagglutinin (HA) protein
is under selective pressure for change in order to evade the
host’s immune system [8]. Antibodies against the HA protein
inhibit receptor binding and are very effective at preventing
reinfection with the same strain. However, HA can change to
evade previously acquired immunity either by antigenic drift,
whereby mutations of the currently circulating HA gene
disrupt antibody binding, or by antigenic shift, in which the
virus acquires an HA of a new subtype by reassortment of one
ormore gene segments.While it is generally accepted that drift
is responsible for inter-pandemic inﬂuenza outbreaks and shift
for pandemics, there are exceptions to this rule. For example,
in 1977, an H1N1 virus re-emerged but failed either to cause a
pandemic or to replace the prevailing H3N2 subtype [9].
The importance of predicting the emergence of new
circulating inﬂuenza strains for subsequent annual vaccine
development cannot be underestimated [10]. To this end, the
global inﬂuenza surveillance network coordinated by the
World Health Organization was established to select the
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candidate strains of inﬂuenza A and B for the yearly produc-
tion of inﬂuenza vaccine in both the northern and southern
hemispheres. The network characterizes the antigenic prop-
erties of inﬂuenza viruses using HA inhibition assays and
sequencing of the HA1 domain (globular head) of HA of a
select number of strains [11,12]. Antigenic, genetic, and
epidemiologic data are then examined to make recommen-
dations of candidate vaccine strains.
A number of retrospective studies have been performed
using partial HA gene sequences to understand, and some-
times predict, the evolution of human H3N2 strains [13–17].
Accumulation of amino acid replacements in HA is clustered
in ﬁve variable antigenic sites [18] around the receptor
binding site. Phylogenetic analysis has revealed that 18
codons in the HA1 domain exhibit signiﬁcantly more non-
synonymous nucleotide substitutions than synonymous ones,
constituting a signature of strong, selectively driven, anti-
genic drift [15]. More recently the antigenic and genetic
evolution of HA was compared through the construction of
an antigenic map of H3N2 viruses [17]. Although antigenic
evolution was found to be more punctuated than genetic
evolution over the same time period, the two measures of HA
drift were generally correlated.
Despite the wealth of data on the molecular evolution of
inﬂuenza viruses, how the entire genome of inﬂuenza A virus
evolves during epidemic years is unclear, particularly as past
sample sizes have been inadequate. While antigenic drift of
HA is clearly of vital importance in the survival of an
inﬂuenza strain, other factors, including HA receptor binding
speciﬁcity [19], antigenic drift of neuraminidase (NA) [20],
matched activity between HA and NA [21–23], and the inter-
action of the other inﬂuenza proteins with each other and
their host cells, are all likely to affect viral ﬁtness in a poly-
genic manner. Similarly, it is unclear how many lineages of
inﬂuenza A viruses persist between seasonal epidemics,
particularly in genes other than that encoding HA.
To this end the National Institute of Allergy and Infectious
Diseases of the National Institutes of Health has funded the
Inﬂuenza Genome Sequencing Project with several partners
[24,25] including the Institute for Genomic Research. To date,
156 genomes of human H3N2 viruses collected between 1999
and 2004 from New York State have been completely sequen-
ced and deposited in GenBank. We have performed an initial
analysis of these viruses and have found evidence for both the
existence of multiple clades of viruses co-circulating at the
same time point and for multiple reassortment events among
these clades. One of these reassortment events was the likely
progenitor of the A/Fujian/411/2002-like drift epidemic of the
2003–2004 inﬂuenza season, in which there was a poor match
between the vaccine strain and the predominant circulating
viruses of that year [26,27]. This report extends recent ob-
servations of reassortant H3N2 inﬂuenza A viruses from the
southern hemisphere during this same time period [28].
Results
Analysis of the Concatenated Complete Genome
of the New York State Influenza Isolates
Three major clusters of sequences were apparent in
phylogenetic trees of the 156 complete genomes of H3N2
inﬂuenza A viruses sampled from New York State. These
corresponded to particular inﬂuenza seasons (winter
months): (a) 1999–2000, (b) 2001–2002 and 2002–2003
together (although only ﬁve members of latter season are
present in these data), and (c) 2003–2004 (Figure 1). Such
temporal structure is commonly observed in trees of
inﬂuenza A virus, and this is thought to be largely driven by
positive selection acting on the HA gene [17]. However, a
number of isolates did not fall into these three groups. First,
three isolates from the 2002–2003 and 2003–2004 seasons—A/
New York/32/2003, A/New York/198/2003, and A/New York/
199/2003—formed a distinct phylogenetic group whose
closest relationship was with those viruses sampled in the
1999–2000 season, rather than with those sampled during
later seasons. We have denoted the two groups of viruses
circulating after the 2001–2002 season as clade A (the major
cluster after the 2001–2002 season) and clade B (the minor
cluster comprising isolates 32, 198, and 199). Second, isolates
A/New York/52/2004 and A/New York/59/2003 (designated as
clade C in Figure 1) occupied a position intermediate
between clade A and the 2001–2002 group of viruses, as did
isolate A/New York/11/2003. Finally, isolates A/New York/137/
1999 and A/New York/138/1999 formed a group that was
divergent from the main group of viruses sampled in the
1999–2000 season.
Analysis of Individual Gene Segments
To investigate the evolutionary history of the outlier
viruses in more detail we inferred phylogenetic trees for
each of the eight individual gene segments (Figure 2).
Strikingly, although the distinction between clades A, B, and
C was apparent in seven of the eight genes, no such
separation was seen in the HA phylogeny. In this case, clades
B and C clearly clustered within clade A and with strong
bootstrap support. The close phylogenetic relationship of
these three groups of viruses in HA set against a background
of genetic divergence in all other segments strongly suggests
that these data contain evidence for at least two independent
reassortment events, one involving clades A and B and
another involving clade C and either clade A or clade B. In
the case of the clade C viruses, the separate gene phylogenies
also reveal that these isolates share a common ancestry with
viruses ﬁrst sampled during the 2001–2002 season, while the
clade B viruses share a closer relationship with those viruses
of the 1999–2000 season.
Two more major phylogenetic displacements suggestive of
reassortment involving other segments were similarly identi-
ﬁed. First, isolate A/New York/11/2003, which fell within clade
A in seven of the gene trees (including HA), clustered with
clade B viruses in PB2. Consequently, isolate A/New York/11/
2003 represents a reassortment of two segments between
clades A and B. Second, isolate A/New York/182/2000, which
clustered with the main set of viruses sampled during the
1999–2000 season in most of the gene trees, was very closely
related to the divergent A/New York/137/1999 and A/New
York/138/1999 isolates in PA and M1, although the high
degree of genetic similarity among all viruses in M1 precludes
a further analysis of reassortment in this case.
To determine the direction of the reassortment events in
HA, we inferred phylogenetic trees of larger datasets compris-
ing theNewYork State isolates and representatives of the other
human and swine H3N2 viruses sampled during the same time
period. Because sequences from the core genes have only been
sporadically collected, this analysis necessarily focused on HA
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Figure 1. Evolutionary Relationships of Concatenated Major Coding Regions of Influenza A Viruses Sampled in New York State during 1999–2004
The maximum likelihood phylogenetic tree is mid-point rooted for purposes of clarity, and all horizontal branch lengths are drawn to scale. Bootstrap
values are shown for key nodes. Isolates assigned to clade A (light blue), clade B (yellow), and clade C (red) are indicated, as are those isolates involved in
other reassortment events: A/NewYork/11/2003 (orange), A/NewYork/182/2000 (dark blue), andA/NewYork/137/1999 andA/NewYork/138/1999 (green).
DOI: 10.1371/journal.pbio.0030300.g001
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andNA.As expected from the phylogenetic analysis of theNew
York State viruses, the distinction between clades A, B, and C
was apparent in the NA gene tree (Figure 3) as well as the core
genes (trees shown inFigure S1).Moreover, in theNAgene tree,
viruses sampled from a variety of locations during 2000–2005
fell into cladeB, includingEurope (Denmark andNorway), Asia
(China and Singapore), and the Americas (Argentina, Brazil,
and the United States). Hence, although clade B was at low
Figure 2. Evolutionary Relationships of Individual Major Coding Regions from Influenza A Viruses Sampled in New York State during 1999–2004
All maximum likelihood phylogenetic trees are mid-point rooted for purposes of clarity only, and all horizontal branch lengths are drawn to scale.
Bootstrap values are shown for clades A, B, and C. Colors are as in Figure 1.
DOI: 10.1371/journal.pbio.0030300.g002
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frequency in theNewYork State dataset, it represents a distinct
lineage of H3N2 viruses globally circulating from at least 2000
to 2005. Similarly, a third North American virus, A/Charlottes-
ville/03/2004, was designated as clade C.
A very different evolutionary history was revealed in HA. In
this case, clade A of the New York State viruses expanded to
contain the majority of viruses sampled after 2002 and from a
variety of locations (Asia, Australasia, Europe, and North
America), as well as a number of Asian viruses from 2002
(Figure 4). This large group of viruses then clustered within
clade B, such that most clade B viruses sampled from 2000 to
2002 formed a clear, but closely related, outgroup to the later
Figure 2. Continued
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clade A viruses, with the remaining clade B viruses falling
within clade A (Figure 4). The three clade C viruses also fell
within this expanded clade A. Such a phylogenetic pattern
strongly suggests that the HA from both the clade A and clade
C viruses was acquired from that present in clade B through
reassortment. In this context it is of interest to note that the
HA of the A/Fujian/411/2002 virus and related isolates are
present in this reassorted clade. Further, the fact that the
clade A and B isolates closest to the phylogenetic location of
the reassortment event were both sampled in 2002 suggests
that the reassortment occurred in this year, although
pinpointing the exact phylogenetic location of the recombi-
nant event is difﬁcult given the relatively small number of
samples available from this critical time period. Similarly, the
fact that these viruses had Asian origins is also compatible
with the reassortment event occurring in this region, a
hypothesis also supported by a recent analysis of comparable
partial genomic analysis of H3N2 isolates from the southern
hemisphere [28].
Analysis of the Coding Differences between Clades A, B,
and C
Because both clade A and clade B contain viruses sampled
on a near global basis, it is important to determine possible
phenotypic differences between them. Table 1 shows the
amino acid replacements that consistently distinguish the
clade A and B viruses. These changes are not uniformly dis-
tributed among the seven segments (not including HA). Of
the 48 amino acid differences between clades A and B, 14 fall
in NA and nine in NP. PB1, PB2, and PA have ﬁve differences
each, while M2 and NS1 have three differences, and M1 and
NS2 have two. In contrast, there are only nine amino acid
differences between the clades A and C: PB2—T9N; PA—
Figure 3. Evolutionary Relationships of 197 NA Sequences Sampled from Mammalian Hosts during 1999–2005
The maximum likelihood phylogenetic tree is mid-point rooted for purposes of clarity only, and all horizontal branch lengths are drawn to scale.
Bootstrap values are shown for clades A, B, and C. Colors are as in Figure 1.
DOI: 10.1371/journal.pbio.0030300.g003
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A20T, L226I, and N272D; NP—G450S; NA—H40Y and V263I;
and NS1—A56T and N143T.
Discussion
Our analysis of whole genomes of H3N2 inﬂuenza A viruses
sampled during 1999–2004 has identiﬁed two key evolu-
tionary patterns. First, although the majority of viruses
isolated after 2002 fall into a single phylogenetic group
(clade A), multiple, co-circulating viral lineages are present at
particular time points. The genetic diversity of inﬂuenza A
virus is therefore not as restricted as previously suggested,
particularly when genes other than that encoding HA are
analyzed. This co-circulation of lineages is most apparent
with the identiﬁcation of three clades of H3N2 viruses that
appear to infect the same populations until 2002, after which
they acquired a common HA gene through reassortment.
Second, and more dramatically, these multiple, co-circulating
lineages may have complex genealogical histories and interact
through reassortment. Indeed, we have documented two
reassortment events involving the HA gene of clade B: one in
which it was acquired by the clade A viruses and another in
which it was independently acquired by those isolates
assigned to clade C. Two further reassortment events
involving the PB2 and PA genes were also evident from our
phylogenetic analysis. Given that we are only able to reliably
detect reassortment when it is associated with major changes
in tree topology, it is likely that reassortment among closely
related lineages is also commonplace in inﬂuenza A viruses.
Reassortment between inﬂuenza A viruses has been
described in both human and animal viruses [1,29]. Notably,
antigenic shift by reassortment between human and avian
inﬂuenza A viruses has been documented in the formation of
the 1957 H2N2 and 1968 H3N2 pandemics [30–32]. Other
recent examples of reassortment between human and animal
inﬂuenza A viruses have resulted in the emergence of novel
Figure 4. Evolutionary Relationships of 256 Sequences of the HA1 Sequences Sampled from Mammalian Hosts during 1999–2004
The maximum likelihood phylogenetic tree is rooted on a divergent set of human and swine viruses for purposes of clarity only, and all horizontal
branch lengths are drawn to scale. Bootstrap values are shown for key nodes. Colors are as in Figure 1, with yellow indicating all those viruses identified
as clade B viruses from the analysis of the expanded NA dataset. The phylogenetic location of the reassortment event between clades A and B was set
at the position of the most basal clade A virus, defined on the basis of the NA analysis, within the older clade B. The phylogenetic locations of the two
critical antigenic mutations at sites 155 and 156 are also shown.
DOI: 10.1371/journal.pbio.0030300.g004
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H3N2 and H1N2 swine viruses in North America and Europe
[33,34] and the evolution of H5N1 viruses in Asia from 1997
to the present [35]. Reassortment between co-circulating
lineages of human inﬂuenza A and more recently inﬂuenza B
viruses following mixed infection has also been described
[36–41]. For example, human H2N2 viruses formed two
distinct clades in the 1960s prior to the emergence of the
1968 H3N2 pandemic virus, with one virus a reassortant
containing genes of both clades [42]. Similarly, the early
H3N2 viruses (1968–1972) acquired the H3 HA and the PB1
gene via reassortment with an avian virus [30,31]. Reassort-
ment between H3N2 and H2N2 viruses may therefore have
assisted successful cross-species transmission [42].
Reassortant viruses were also described following the re-
emergence of the H1N1 subtype in 1977 that did not replace
the previously circulating H3N2 viruses. In this case, co-
circulation of inﬂuenza viruses of both subtypes continued,
and co-infection with both subtypes was reported [43]. While
reassortant H3N1 strains were not isolated, H1N1 strains
containing reassorted internal protein-encoding gene seg-
ments from H3N2 viruses were observed [44,45]. Occasional
isolates of H1N2 viruses were also detected after the re-
emergence of H1N1 [46,47]. More recently, the widespread
circulation of viruses with the H1N2 subtype has been
documented [41]. These viruses contained the HA segment of
contemporary H1N1 viruses reassorted onto an H3N2 back-
ground, a 7:1 reassortment pattern similar to that observed
with the sporadically circulatingH1N2 viruses of the 1980s and
early 1990s [47] and to the dominant reassortments described
in this analysis. Since the H1 and N2 subtype proteins were
antigenically and genetically similar to co-circulating H1N1
and H3N2 subtype viruses, the emergence of this new subtype
did not result in an epidemiologically signiﬁcant event [41].
Reassortment among co-circulating clades of H3N2 viruses
like that observed in the current study has also been previously
described, including reassortment of theNA gene segment [48]
and the core protein-encoding segments [49].
Most prior phylogenetic studies of human inﬂuenza A have
suggested that inter-pandemic evolution may be essentially
described as a series of successions by variants of the previous
season’s dominant strain. These successions are largely deter-
mined by strong positive selection acting on the abundance of
mutational diversity in the HA of the dominant strain. How-
ever, we found that at least four reassortment events occurred
among human viruses during the period 1999–2004 and that
two of these involved a major change in HA. Recently, Barr et
al. independently provided phylogenetic evidence of the clade
A–clade B reassortment described here in an analysis of pre-
dominantly southern hemispheric inﬂuenza A H3N2 isolates
collected during the same period [28]. To our knowledge,
these analyses are the ﬁrst demonstrations of the emergence
of a major antigenically variant virus derived by reassortment
between two distinct clades of co-circulating H3N2 viruses
rather than by antigenic drift. These ﬁndings suggest that the
ongoing evolution of human inﬂuenza A virus is likely to be
more complex than depicted in standard models of antigenic
drift; multiple lineages of antigenically distinct viruses can
persist within populations and, through their reassortment,
produce major changes in antigen space. Similarly, the
persistence of multiple lineages of H3N2 within a single
population indicates that human populations represent a
larger reservoir of genetically distinct viruses than previously
anticipated. Indeed, it is possible that key changes in antigen
type, depicted as jumps between cluster types [17], could be
strongly inﬂuenced by reassortment among co-circulating
human strains. Crucially, the real importance of both lineage
persistence and reassortment in inﬂuenza A virus evolution
could not be determined until a representative sample of full-
genome sequences was collected from a single population.
In the 2003–2004 inﬂuenza season, a major drift variant
emerged in both the northern and southern hemispheres [50–
52]—the A/Fujian/411/2002-like variant. In the United States,
the 2001–2002 inﬂuenza was an H3N2-predominant season,
and all antigenically characterized isolates matched the A/
Moscow/10/1999 vaccine strain [53]. In the 2002–2003 season,
which was an H1- and inﬂuenza B–dominant season in the
United States, a minority of antigenically characterized H3N2
isolates were different from the Moscow/10/1999-like vaccine
strain [54], probably coinciding with the emergence of the
Fujian strain. Indeed, in our phylogenetic analysis two of ﬁve
H3N2 viruses from the 2002–2003 season fall into clade B,
along with two newly sequenced isolates that were not
included in our analysis (A/New York/201/2003 and A/New
York/203/2003). Consequently, clade B viruses made up a
signiﬁcant fraction of the few H3N2 isolates in that season. In
contrast, only a small minority of inﬂuenza H3N2 viruses
sampled in Europe at this time were antigenically charac-
terized as Fujian-like [50], while in the southern hemisphere’s
2003 inﬂuenza season the Fujian strain was predominant
[28,51]. The 2003–2004 inﬂuenza season in the northern
hemisphere was also dominated by the Fujian strain [55],
although the vaccine contained the H3N2 (A/Panama/2007/
1999) from the previous year. This strain was a poor antigenic
match to the Fujian strain [26,27], which in turn led to
reduced vaccine effectiveness. Thirteen amino acid changes
distributed across the ﬁve antigenic sites of the HA1 domain
distinguish the A/Panama/2007/1999-like and A/Fujian/411/
2002-like strains. While these replacement changes appear to
have phenotypic consequences (e.g., replication efﬁciency in
eggs), only two residues, 155 and 156, are responsible for the
major antigenic differences between the strains [27].
Although data are insufﬁcient for precise determination of
Table 1. Amino Acid Changes Between the Proteins Encoded
by the Clade A and Clade B Viruses
PB2 PB1 PA NP NA M1 M2 NS1 NS2
T9Na I179M N27D S27A A18S T218A N23S G71E R87K
R340K I469T R262K R77K L23F V219I I51V A82V G26D
K389R K586R T332S K98R V30I R56K N143T
G590S D619N V348I R103K H40Y
V667I V709I V421I M136I C42F
I197V G143V
I406T R172K
I425V K199E
E480D G216V
I265T
V307I
K385N
E399D
W437L
aClade A isolates have the amino acid before position number; changed amino acid in clade B follows the position
number.
DOI: 10.1371/journal.pbio.0030300.t001
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the timing of these two critical mutations, the available data
are most consistent with these changes occurring in a
relatively short time period before the reassortment event.
The histidine to threonine change at site 155 and the
glutamine to histidine change at site 156 are present in all
the clade A reassortant isolates as well as in clade B isolates
from 2003–2004, thus suggesting that they occurred prior to
the reassortment event. No available clade B isolates prior to
2002–2003 have either of these mutations, and we were able
to identify only three ‘‘intermediate’’ isolates from 2002–2003
(A/Kwangju/219/2002, A/Kwangju/243/2002, and A/Cheonnam/
340/2002) with the replacement at site 155 but not at site 156.
Overall, the data presented here, coupled with those recently
reported [28], reveal that the HA segment of the H3N2 clade
B viruses, present in low frequencies at least since 1999, was
reassorted into clade A of H3N2, probably in 2002 soon after
the appearance of these two critical mutations, and that this
reassortment was central to the production of antigenically
variant strains that were poorly matched to the vaccine strain
in the 2003–2004 season [27]. In addition, presumably
because of the high rate of reassortment and the ﬁtness
advantage conferred by these two mutations, this clade B HA
segment also appeared to replace the HA segment of the
clade C strains. Finally, though previously present only in low
frequencies, recent sequencing of HA and NA by investi-
gators in Denmark [56] and published phylogenetic trees
from Australia [28,51] show the existence of clade B virus,
suggesting that it continued to have a global distribution and
sometimes at appreciable frequency.
Several questions remain unanswered by our study. Since
the HA donated by clade B led to a major expansion of the
reassorted clade A, it is uncertain why clade B did not initially
out-compete clade A without reassortment. One possibility is
that the HA of clade B had an intrinsically higher ﬁtness than
other HAs circulating at the same time but was unable to
reach a high frequency in the New York population owing to
linkage to mutations located in other segments that reduced
the overall ﬁtness of this genotype. According to this
hypothesis, it was not until it was placed by reassortment
into a more favorable genetic background, in this case the
clade A viruses, that its ﬁtness advantage was realized. Since
clade B itself appeared to proliferate in other regions, it will
be useful to analyze whole-genome sequence from these
isolates when they are available.
More generally, it is clear that the genotypic basis to viral
ﬁtness has not been entirely elucidated. In particular, it is
likely that interactions among viral proteins and between
viral proteins and host factors play a key role. In this respect
it is notable that of the 48 amino acid differences that
distinguish the clade B viruses, nine fall in NP and 14 fall in
NA (see Table 1). In NP, the replacement at residue 425 falls
within an HLA-B35-restricted cytotoxic T lymphocyte (CTL)
epitope and is not commonly seen in human populations [57].
Two other changes, at residues 27 and 197, have also been
identiﬁed as being contained in two HLA-A11-restricted CTL
epitopes [58]. Another unusual change in NP is M136I: a
change to methionine at this site was proposed as one of six
human adaptive changes distinguishing the 1918 NP from
avian NPs [59]. Indeed, all 45 available NP sequences from
human H2N2 viruses, and all but four of approximately 250
human H3N2 NP sequences, maintain this methionine. Only
the three New York clade B viruses, as well as A/Taiwan/1/71,
have a change to an isoleucine at this residue. Of the changes
in NA, six of them lie in ﬁve regions previously identiﬁed as
being phylogenetically important regions, residues 40, 42,
143, 199, 307, and 385 [60], and therefore play a role in virus–
host interaction. Three further changes, at residues 172, 199,
and 307, map to antigenic sites [20], while a change at residue
18 has been mapped as an HLA-A2-restricted CTL epitope
[58]. Similarly, two changes in M2, at residues 51 and 56, map
to an HLA-A11-restricted CTL epitope, while residue 82 of
NS1 maps to an HLA-A2-restricted CTL epitope [58].
Another change between clade A and B viruses, at residue
226 of PA, also maps to an HLA-A2-restricted CTL epitope
[58]. It is possible that some of the mutations that fall in CTL
epitopes assist the persistence of clade B by elongating the
viral infectious period [61]. However, any combination of the
constellation of amino acid changes may have altered the
ﬁtness of the clade B viruses in a way that we do not have the
ability to understand from sequence analysis alone. Interest-
ingly, Gulati et al. [62] have recently shown that Fujian-like
strains have a mismatch in their HA and NA activities that is
probably the result of the reassortment event described in the
current study. The signiﬁcance of this for the pathophysiol-
ogy of the virus is currently unknown.
In summary, our study clearly demonstrates the utility of
whole-genome analyses of inﬂuenza A viruses, and further
makes clear that additional whole-genome analyses are
required to understand fully the evolutionary mechanisms
and epidemiological dynamics of this virus. While antigenic
variance of HA is still the dominant selective pressure on
human inﬂuenza A virus evolution, the ﬁnding that antigeni-
cally novel clades emerge by reassortment among persistent
viral lineages rather than via antigenic drift is of major
signiﬁcance for vaccine strain selection.
Materials and Methods
Inﬂuenza viruses used in this study. The inﬂuenza virus isolates
were collected as part of the diagnostic service provided by the Virus
Reference and Surveillance Laboratory at the Wadsworth Center,
New York State Department of Health. Viruses were received as part
of outbreak investigations, through the reference function of the
laboratory, and, since 2001, as part of a sentinel physician inﬂuenza
surveillance program. Viruses were passaged minimally in primary
rhesus monkey kidney cell culture and the RNA extracted from the
clariﬁed supernatant. Whole-genome sequence information was
derived at the Institute for Genomic Research using methods de-
scribed elsewhere (E. Ghedin, N. A. Miller, M. Shumway, J. Zaborsky,
T. Feldblyum, et al., unpublished data). Use of the diagnostic samples
in this study was approved by the New York State Department of
Health Institutional Review Board.
Sequences used in the analysis. Sequence data for 156 complete
genomes of inﬂuenza A virus (H3N2) sampled from New York State
during the period 1999–2004 were downloaded from GenBank (1,248
separate accessions, representing the eight gene segments of 156
individual inﬂuenza isolates; GenBank accession numbers available
from http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html). Separate
sequence alignments were then manually compiled for the major
coding regions of each segment: PB2, 2,277 bp; PB1, 2,271 bp (PB1
protein); PA, 2,148 bp; HA, 1,698 bp; NP, 1,494 bp; NA, 1,407 bp; MP,
756 bp (M1 protein); and NS, 690 bp (NS1 protein). An alignment of
the concatenated major coding regions was also constructed for all
156 isolates (12,741 bp). To place the New York State viruses in the
context of global H3N2 evolution, larger datasets were complied
comprising the New York State isolates plus all other mammalian
inﬂuenza A viruses sampled from 1999–2004 available on GenBank
and the Los Alamos Inﬂuenza Sequence Database (http://www.ﬂu.lanl.
gov/). For the six core genes, few such background sequences were
available, particularly from clades B and C (see below). However, far
larger numbers of background sequences were available for the HA1
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domain portion of HA and for sequence of NA genes. To facilitate the
computational analysis of these background datasets, those New York
State isolates with identical sequences were removed from the analysis.
This resulted in alignments of the following sizes: PB2, 134 sequences,
2,277 bp; PB1, 135 sequences, 2,271 bp; PA, 140 sequences, 2,148 bp;
HA, 256 sequences, 987 bp; NP, 117 sequences, 1,494 bp; NA, 197
sequences, 1,407 bp; M1, 73 sequences, 756 bp; and NS1, 75 sequences,
690 bp. A full list of the isolates used in this study is provided in
Table S1.
Phylogenetic analysis. Phylogenetic trees were inferred for all of
the datasets described above using the maximum likelihood method
available in the PAUP* package [63] (see Table S2). In each case the
general time-reversible model of nucleotide substitution was used
also incorporating a proportion of invariable sites and a gamma
distribution of rate variation among sites with four rate categories.
All parameter values were estimated from the empirical data and are
given in Table S2. Tree bisection–reconnection branch-swapping was
used in all cases apart from the expansive (‘‘background’’) HA and NA
datasets, which contained so many sequences that the analysis was
restricted to subtree pruning–regrafting branch-swapping. To assess
the reliability of key nodes on the phylogenetic trees, a bootstrap
resampling analysis was also undertaken in each case. This involved
the inference of 1,000 replicate neighbor-joining trees using the
maximum likelihood substitution model inferred for each dataset.
Supporting Information
Figure S1. Phylogenetic Trees of New York State and Background
H3N2 Strains Inferred from the Core Genes
Maximum likelihood phylogenetic trees depicting the evolutionary
relationships of the remaining six segments (major coding regions
only) from the H3N2 inﬂuenza A viruses sampled in New York State
during the period 1999–2004 (unique sequences only) and the
‘‘background’’ viruses taken from GenBank or the Los Alamos
Inﬂuenza Sequence Database. All trees are mid-point rooted for
purposes of clarity only, and all horizontal branch lengths are drawn
to scale. Bootstrap values are shown for clades A, B, and C. Colors are
as in Figure 1.
Found at DOI: 10.1371/journal.pbio.0030300.sg001 (715 KB EPS).
Table S1. Isolates of Inﬂuenza A Virus H3N2 Used in This Study
Found at DOI: 10.1371/journal.pbio.0030300.sg001 (164 KB DOC).
Table S2. Parameter Values for Maximum Likelihood Phylogenetic
Analysis
Found at DOI: 10.1371/journal.pbio.0030300.sg001 (50 KB DOC).
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